NSN 6505-01-535-6120
Part Details | SERTRALINE HYDROCHLORIDE TABLETS
6505-01-535-6120
Alternate Parts: NDC76282021330, NDC76282-0213-30, NDC76282021330, NDC76282-0213-30, 051914, 05-1914, NDC76282021330, NDC76282-0213-30, ZOLOFT, NDC00049490030, NDC00049-4900-30, 6505-01-535-6120, 01-535-6120, 6505015356120, 015356120
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | DEC 06, 2005 | 01-535-6120 | 48238 ( SERTRALINE HYDROCHLORIDE TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-535-6120
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC76282-0213-30 | 1XUY5 | AMERISOURCEBERGEN DRUG CORPORATIONDIV CORPORATE OFFICE |
| NDC76282-0213-30 | 00E55 | CARDINAL HEALTH, INC.DBA CARDINAL HEALTH |
| 05-1914 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC76282-0213-30 | 6GFC4 | EXELAN PHARMACEUTICALS INCDIV EXELAN PHARMACEUTICALS |
| ZOLOFT | 00YG0 | PFIZER PHARMACEUTICALS |
| NDC00049-4900-30 | 00YG0 | PFIZER PHARMACEUTICALS |
Technical Data | NSN 6505-01-535-6120
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BZ50.000 MILLIGRAMS SERTRALINE |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.000 TABLETS |
| PROTECTIVE STORAGE FEATURE | REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 281604 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SERTRALINE HYDROCHLORIDE TABLETS 50MG BT 30S |
